EMA lists rare spinal condition as side effect of AstraZeneca’s COVID-19 shot
Jan 14 (Reuters) - A safety panel of the European drug regulator on Friday recommended adding a rare spinal inflammation called transverse myelitis as a side effect of AstraZeneca's COVID-19…
